ARMATA PHARMACEUTICALS, INC. License and Services Revenue (Deprecated 2018-01-31)
ARMATA PHARMACEUTICALS, INC. (ARMP) reported License and Services Revenue (Deprecated 2018-01-31) of $115.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-25.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2019-03-25
- ARMATA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $20.00K, a 9.09% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $38.00K, a 31.03% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $28.00K, a 72.82% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $29.00K, a 72.64% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2017 was $115.00K, a 55.77% decline from fiscal 2016.
- ARMATA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2016 was $260.00K, a 45.26% decline from fiscal 2015.
- ARMATA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2015 was $475.00K, a 16.14% increase from fiscal 2014.
- ARMATA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2014 was $409.00K.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 3 month as first filed | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month | License and Services Revenue (Deprecated 2018-01-31) 12 month | License and Services Revenue (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $58.00K derived: sum of 2 quarters · filed 2019-03-25 | $86.00K derived: sum of 3 quarters · filed 2019-03-25 | $115.00K 10-K · filed 2019-03-25 | ||
| 2017-09-30 | $38.00K 10-Q · filed 2018-11-08 | $66.00K derived: sum of 2 quarters · filed 2018-11-08 | $95.00K 10-Q · filed 2018-11-08 | $117.00K derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2017-06-30 | $28.00K 10-Q · filed 2018-08-09 | $57.00K 10-Q · filed 2018-08-09 | $79.00K derived: sum of 3 quarters · filed 2018-08-09 | $108.00K derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-03-31 | $29.00K 10-Q · filed 2018-05-15 | $51.00K derived: sum of 2 quarters · filed 2018-05-15 | $80.00K derived: sum of 3 quarters · filed 2018-05-15 | $183.00K derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $22.00K 10-K · filed 2017-03-27 | $51.00K derived: sum of 2 quarters · filed 2017-11-14 | $154.00K derived: sum of 3 quarters · filed 2017-11-14 | $260.00K 10-K · filed 2018-03-14 | ||
| 2016-09-30 | $29.00K 10-Q · filed 2017-11-14 | $132.00K derived: sum of 2 quarters · filed 2017-11-14 | $238.00K 10-Q · filed 2017-11-14 | $366.00K derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | $103.00K 10-Q · filed 2017-08-14 | $209.00K 10-Q · filed 2017-08-14 | $337.00K derived: sum of 3 quarters · filed 2017-08-14 | $480.00K derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $106.00K 10-Q · filed 2017-05-15 | $234.00K derived: sum of 2 quarters · filed 2017-05-15 | $377.00K derived: sum of 3 quarters · filed 2017-05-15 | $479.00K derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2015-12-31 | $128.00K 10-K · filed 2017-03-27 | $271.00K derived: sum of 2 quarters · filed 2017-03-27 | $373.00K derived: sum of 3 quarters · filed 2017-03-27 | $475.00K 10-K · filed 2017-03-27 | ||
| 2015-09-30 | $143.00K 10-K · filed 2017-03-27 | $245.00K derived: sum of 2 quarters · filed 2017-03-27 | $347.00K 10-Q · filed 2016-11-10 | $448.00K derived: sum of 4 quarters · filed 2017-03-27 | ||
| 2015-06-30 | $102.00K 10-K · filed 2017-03-27 | $204.00K 10-Q · filed 2016-08-15 | $305.00K derived: sum of 3 quarters · filed 2017-03-27 | $408.00K derived: sum of 4 quarters · filed 2017-03-27 | ||
| 2015-03-31 | $102.00K 10-K · filed 2017-03-27 | $203.00K derived: sum of 2 quarters · filed 2017-03-27 | $306.00K derived: sum of 3 quarters · filed 2017-03-27 | $407.00K derived: sum of 4 quarters · filed 2017-03-27 | ||
| 2014-12-31 | $101.00K 10-K · filed 2016-03-30 | $204.00K derived: sum of 2 quarters · filed 2016-03-30 | $305.00K derived: sum of 3 quarters · filed 2016-03-30 | $409.00K 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $103.00K 10-K · filed 2016-03-30 | $204.00K derived: sum of 2 quarters · filed 2016-03-30 | $308.00K 10-Q · filed 2015-11-16 | |||
| 2014-06-30 | $101.00K 10-K · filed 2016-03-30 | $205.00K 10-Q · filed 2015-08-13 | ||||
| 2014-03-31 | $104.00K 10-K · filed 2016-03-30 | $0.00 10-Q · filed 2014-09-12 | ||||
| 2013-12-31 | $81.00K 10-Q/A · filed 2015-04-15 | $325.00K 10-Q · filed 2014-09-12 | ||||
| 2013-03-31 | $22.00K 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |